Determination of a Phase II Dose of Panobinostat in Combination with 5-Azacitidine in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

被引：0
|
作者：
Ottmann, Oliver G. [1 ]
DeAngelo, Daniel J. [2 ]
Garcia-Manero, Guillermo [3 ]
Luebbert, Michael [4 ]
Jillella, Anand [5 ]
Sekeres, Mikkael A. [6 ]
Zahlten, Anita [7 ]
Squier, Margaret [8 ]
Acharyya, Suddhasatta [8 ]
Winiger, Ivo J. [7 ]
Fenaux, Pierre [9 ]
机构：
[1] Goethe Univ Frankfurt, Dept Internal Med, Frankfurt, Germany
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Freiburg, D-79106 Freiburg, Germany
[5] Georgia Hlth Sci Univ, Augusta, GA USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Hop Avicenne, AP HP, F-93009 Bobigny, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：212 / 213
页数：2
相关论文
共 50 条
  • [21] Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study
    Navada, Shyamala C.
    Garcia-Manero, Guillermo
    OdchimarReissig, Rosalie
    Pemmaraju, Naveen
    Alvarado, Yesid
    Ohanian, Maro N.
    John, Rosmy B.
    Demakos, Erin P.
    Zbyszewski, Patrick S.
    Maniar, Manoj
    Woodman, Richard C.
    Fruchtman, Steven M.
    Silverman, Lewis R.
    LEUKEMIA RESEARCH, 2020, 94
  • [22] Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine
    Kuendgen, Andrea
    Mueller-Thomas, Catharina
    Urbaniak, Petra
    Lauseker, Michael
    Haferlach, Torsten
    Alpermann, Tamara
    Albuquerque, Andreia
    Kohlmann, Alexander
    Schnittger, Susanne
    Hildebrandt, Barbara
    Royer-Pokora, Brigitte
    Gattermann, Norbert
    Haas, Rainer
    Germing, Ulrich
    Goetze, Katharina
    BLOOD, 2013, 122 (21)
  • [23] Phase 1 study of LP-108 as monotherapy and in combination with azacitidine in patients with relapsed or refractory myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML).
    Walker, Alison R.
    Bergua Burgues, Juan Miguel
    Montesinos, Pau
    Bixby, Dale
    Guastad Daver, Naval
    Konopleva, Marina
    Patrick Anthony, Stephen
    Tan, Fenlai
    Chen, Yi
    Chen, Yu
    Shen, Yue
    William Burke, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Glasdegib in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia: Effects on Marrow Recovery and Transfusion Independence
    Zeidan, Amer
    Schuster, Michael
    Joris, Magalie
    Krauter, Juergen
    Maertens, Johan
    Gyan, Emmanuel
    Kovacsovics, Tibor
    Verma, Amit
    Vyas, Paresh
    Wang, Eunice
    Ma, Weidong
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Sekeres, Mikkael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S191 - S192
  • [25] A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia
    Tantravahi, Srinivas K.
    Szankasi, Philippe
    Khorashad, Jamshid S.
    Dao, Kim-Hien
    Kovacsovics, Tibor
    Kelley, Todd W.
    Deininger, Michael W.
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2441 - 2444
  • [26] Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
    Kenealy, Melita
    Patton, Nigel
    Filshie, Robin
    Nicol, Andrew
    Ho, Shir-Jing
    Hertzberg, Mark
    Mills, Tony
    Prosser, Ian
    Link, Emma
    Cowan, Linda
    Zannino, Diana
    Seymour, John F.
    LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 298 - 307
  • [27] TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH 5-AZACITIDINE: A CASE SERIES
    Moita, F.
    Thorpe, M.
    Almeida, A.
    HAEMATOLOGICA, 2012, 97 : 588 - 588
  • [28] An unusual response to 5-azacitidine by a patient with chronic myelomonocytic leukemia
    Islam, Anwarul
    CLINICAL CASE REPORTS, 2023, 11 (08):
  • [29] Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia—a wise Liaison?
    U Platzbecker
    U Germing
    Leukemia, 2013, 27 : 1813 - 1819
  • [30] RESULTS OF THE USE OF 5-AZACITIDINE IN OLD PATIENTS DIAGNOSED OF CHRONIC MYELOMONOCYTIC LEUKEMIA
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Martin Sonia, Herreo
    Perez Dolores, Subira
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 344 - 344
12345